Search

Author/Creator Monrad, Ida

1. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. (May 2021)

Authors:
Gunst, Jesper D.; Staerke, Nina B.; Pahus, Marie H.; Kristensen, Lena H.; Bodilsen, Jacob; Lohse, Nicolai; Dalgaard, Lars S.; Brønnum, Dorthe; Fröbert, Ole; Hønge, Bo; Johansen, Isik S.; Monrad, Ida; Erikstrup, Christian; Rosendal, Regitze; Vilstrup, Emil; Mariager, Theis; Bove, Dorthe G.; Offers...
Journal:
EClinicalMedicine
Issue:
Volume 35(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution. (4th June 2021)

Authors:
Monrad, Ida; Sahlertz, Signe Risgaard; Nielsen, Stine Sofie Frank; Pedersen, Louise Ørnskov; Petersen, Mikkel Steen; Kobel, Carl Mathias; Tarpgaard, Irene Harder; Storgaard, Merete; Mortensen, Klaus Leth; Schleimann, Mariane H; Tolstrup, Martin; Vibholm, Line K
Journal:
Open forum infectious diseases
Issue:
Volume 8:Number 7(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Soluble programmed cell death protein 1 (sPD‐1) and the soluble programmed cell death ligands 1 and 2 (sPD‐L1 and sPD‐L2) in lymphoid malignancies. (12th April 2021)

Authors:
Mortensen, Julie B.; Monrad, Ida; Enemark, Marie B.; Ludvigsen, Maja; Kamper, Peter; Bjerre, Mette; d'Amore, Francesco
Journal:
European journal of haematology
Issue:
Volume 107:Number 1(2021)
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗